Article Text

Download PDFPDF
Reminder of important clinical lesson
Life-threatening hyponatraemia
  1. Emmanuel Eroume A Egom1,
  2. Kenneth Y-K Wong2,
  3. Andrew L Clark2
  1. 1Academic Cardiology, University of Hull, Hull and East Yorkshire Hospitals, Kingston upon Hull, UK
  2. 2Academic Cardiology, University of Hull, Kingston upon Hull, UK
  1. Correspondence to Dr Emmanuel Eroume A Egom, eeroumeaegom{at}doctors.org.uk

Summary

A 31-year-old hypertensive woman was admitted to hospital with palpitations. Her hypertension was treated with bendroflumethiazide, which had been increased from 2.5 to 5 mg daily by her general practitioner about 18 months prior to her admission. She was also on ramipril 10 mg once daily. There were no abnormal findings on examination, and a 12-lead ECG showed sinus rhythm, rate 75, with Q waves in leads V1–V2. Telemetry (over 24 h) showed ventricular bigeminy when she had her typical palpitations. Her admission serum sodium and potassium concentrations were 132 and 3.4 mmol/l, respectively. Immediately prior to planned discharge the following day, she experienced paraesthesiae, weakness, confusion and seizures accompanied by 10 s asystole on the ECG monitor. Her serum sodium had fallen to 120 mmol/l and potassium to 2.3 mmol/l. Bendroflumethiazide and ramipril were discontinued and the patient was restricted to fluids of 1.5 l/24 h. She also received potassium supplements. Her serum sodium concentration rose to normal over 6 days, and she was discharged on feeling well.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Competing interests None.

  • Patient consent Obtained.